Research Progress of Magnesium in Pathogenesis and Treatment of Migraine

doi:10.3969/j.issn.2095-1396.2020.01.007

Abstract

Abstract:

Magnesium is the second most abundant cation in cells and plays an important role in many life activities.Magnesium deficiency can induce cerebral spreading depression（CSD），promote platelet aggregation，affect the function of 5-HT receptor and the synthesis and release of a variety of neurotransmitters.Migraine is a highly prevalent and disabling neurological disease with a complex and diverse pathogenesis that remains unclear. In recent years，the role of magnesium in migraine has received increasing attention. Some studies have shown that oral or intravenous magnesium supplementation can treat and prevent migraine attacks. This paper reviews the role of magnesium in the pathogenesis and treatment of migraine in order to provide more theoretical basis for clinical treatment of migraine.

Key words: magnesium, migraine, pathogenesis, treatment and preventive medication

ZHANG Li-huan, CHU Bao, ZHANG Xiao-yan, SUN Ying-ru, GONG Chun-dong, WANG He-bo. Research Progress of Magnesium in Pathogenesis and Treatment of Migraine[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 29-33.

References

[1] Theo Vos, Amanuel A Abajobir, Cristiana Abbafati, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet, 2017, 390(10100):1211-1259.

[2]于生元. 从宏观到微观认识头痛[J]. 中国疼痛医学杂志, 2014, 20(1):2-4.

[3]赵维民, 张波. 偏头痛发病机制的研究进展[J]. 中医药临床杂志, 2015(1):14-15.

[4]于挺敏, 姚刚. 镁与偏头痛[J]. 中国疼痛医学杂志, 2008,14(1):39-41.

[5]Grober Uwe, Schmidt Joachim, Kisters Klaus. Magnesium in prevention and therapy[J]. Nutrients, 2015, 7(9):8199-8226.

[6] Abdullah M Al Alaw, Sandawana William Majoni, Henrik Falhammar. Magnesium and human health: perspectives and research directions[J]. Int J Endocrinol, 2018,1: 9041694.

[7]Carrie Armstrong. AAN/AHS update recommendations for migraine prevention in adults [J]. Am Fam Physician, 2013, 87(8):584-585.

[8]Tamara Pringsheim, Gordon Mackie, Irene Worthington, et al. Canadian Headache Society guideline for migraine prophylaxis[J]. Can J Neurol Sci, 2012, 39(2 Suppl 2):S1-59.

[9] A Straube, Charly Gaul, S Forderreuther, et al. [Therapy and care of patients with chronic migraine: expert recommendations of the German Migraine and Headache Society/German Society for Neurology as well as the Austrian Headache Society/Swiss Headache Society][J]. Nervenarzt, 2012, 83(12):1600-1608.

[10] Jan Hoffmann, Andrew Charles. Glutamate and its receptors as therapeutic targets for migraine[J]. Neurotherapeutics, 2018,15(Suppl 1):1-10.

[11]张红亚, 张红云, 师天元, 等. 偏头痛患者颈静脉血血小板活化能力和血管内皮素及镁水平的变化[J]. 中国全科医学, 2007,10(11):886-887.

[12] Afshin Samaie, Nabiollah Asghari, Raheb Ghorbani,et al. Blood Magnesium levels in migraineurs within and between the headache attacks: a case control study[J]. Pan Afr Med J, 2012, 11(11):46.

[13] Federica I Wolf, Valentina Trapani, Achille R M Cittadini. Magnesium and the control of cell proliferation: looking for a needle in a haystack[J]. Magnes Res, 2008, 21(2):83-91.

[14] Federica I Wolf, Valentina Trapani, Achille Cittadini, et al. Neuroprotective effect of magnesium acetyltaurate against NMDA-induced excitotoxicity in rat retina[J]. Neurotox Res, 2017, 31(1):31-45.

[15]Peter J Goadsby, Philip R Holland, Margarida Martins-Oliveira, et al. Pathophysiology of migraine: a disorder of sensory processing[J]. Physiol Rev, 2017, 97(2):553-622.

[16] Peter J Goadsby. Migraine: emerging treatment options for preventive and acute attack therapy[J]. Expert Opin Emerg Drugs, 2006, 11(11):419-427.

[17] Bandara Rathnasiri, Mudiyanselage Senanayake. Paranasal sinus nitric oxide and migraine: a new hypothesis on the sino rhinogenic theory[J]. Med Hypotheses, 2013, 80(4):329-340.

[18]Petur Ludvigsson, Dale Hesdorffer, Elias Olafsson ,et al. Migraine with aura is a risk factor for unprovoked seizures in children[J]. Ann Neurol, 2010, 59(1):210-213.

[19] Vincenza Gorgoglione, Daniela Laraspata, Gianluigi La Piana, et al. Protective effect of magnesium and potassium ions on the permeability of the external mitochondrial membrane[J]. Arch Biochem Biophys, 2007, 461(1):13-23.

[20] Giovanni D'Andrea, A Leon. Pathogenesis of migraine: from neurotransmitters to neuromodulators and beyond[J]. Neurol Sci, 2010, 31 Suppl 1(1):S1-7.

[21] Florindo D'Onofrio, Simona Raimo, Daniele Spitaleri, et al. Usefulness of nutraceuticals in migraine prophylaxis[J]. Neurol Sci, 2017, 38(1):117-120.

[22] Nabih Ramadan, H R Halvorson, A Vande-Linde, et al. Low brain magnesium in migraine[J]. Headache, 2010, 29(7):416-419.

[23]Anna E Kirkland, Gabrielle L Sarlo, Kathleen F Holton. The role of magnesium in neurological disorders[J]. Nutrients, 2018, 10(6):730.

[24]Charly Gaul, Hans-Christoph Diener, Ulrich Danesch. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial[J]. J Headache Pain, 2015, 16(1):516.

[25]Ali Shahrami, Farhad Assarzadegan, Hamid Reza Hatamabadi, et al. Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone/metoclopramide on alleviating acute migraine headache[J]. J Emerg Med, 2015, 48(1):69-76.

[26] Emily Gertsch, Sheila Loharuka, Kristine Wolter-Warmerdam, et al. Intravenous magnesium as acute treatment for headaches: a pediatric case series[J]. J Emerg Med, 2014, 46(2):308-312.

[27] Hsiao-Yean Chiu, Tu-Hsueh Yeh, Yin-Cheng Huang, et al. Effects of intravenous and oral magnesium on reducing migraine: a meta-analysis of randomized controlled trials[J]. Pain Physician, 2016, 19(1):E97-112.

[28]A Peikert, C Wilimzig, R Kohne-Volland. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study[J]. Cephalalgia, 2010, 16(4):257-263.

[29] Morris Maizels, Andrew Blumenfeld, Raoul Burchette. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial[J]. Headache, 2010, 44(9):885-890.

[30] Seref Demirkaya, Okay Vural, Babur Dora, et al. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks[J]. Headache, 2010, 41(2):171-177.

[31] Alireza Baratloo, Sahar Mirbaha, Hossein Delavar Kasmaei, et al. Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study[J]. Korean J Pain, 2017, 30(3):176-182.

[32] Hossein Delavar Kasmaei, Marzieh Amiri, Ahmed Negida, et al. Ketorolac versus magnesium sulfate in migraine headache pain management; a preliminary study[J]. Emerg (Tehran), 2017,5(1)：2.

[33] Michael J Marmura, Stephen D Silberstein, Todd J Schwedt. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies[J]. Headache, 2015, 55(1):3-20.

[34] Luca Gallelli, Tiziana Avenoso, Daniela Falcone, et al. Effects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium[J]. Headache, 2014, 54(2):313-324.

[35] Oved Daniel, Alexander Mauskop. Nutraceuticals in acute and prophylactic treatment of migraine[J]. Curr Treat Options Neurol, 2016, 18(4):1-8.

[36]Serena L Orr, Sunita Venkateswaran. Nutraceuticals in the prophylaxis of pediatric migraine: evidence-based review and recommendations[J]. Cephalalgia, 2014, 34(8):568-583.

[37] R Sangermani, A Boncimino. The use of nutraceutics in children’s and adolescent’s headache[J]. Neurol Sci, 2017, 38(Suppl 1):121-124.

[38]Farhad Assarzadegan, Setareh Asgarzadeh, Hamid R Hatamabadi, et al. Serum concentration of magnesium as an independent risk factor in migraine attacks: a matched case-control study and review of the literature[J]. Int Clin Psychopharmacol, 2016, 31(5):287-292.

[39]Fanny Xu, Anush Arakelyan, Andrew Spitzberg, et al. Experiences of an outpatient infusion center with intravenous magnesium therapy for status migrainosus[J]. Clin Neurol Neurosurg, 2019, 178: 31-35.

[40]胡昌盛, 周良斌. 丙戊酸镁联合文拉法辛防治偏头痛54例的临床疗效观察[J]. 中国当代医药, 2011, 18(10): 62-63.

[41]杜文兵, 罗远带, 甄丽芳, 等. 丙戊酸镁治疗偏头痛有效性和安全性的Meta分析[J]. 中西医结合心脑血管病杂志, 2013, 11(5): 560-561.

Research Progress of Magnesium in Pathogenesis and Treatment of Migraine

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 13

Recommended Articles

Metrics

[1]	GENG Xin-yu, SHANG Wen-xuan, LI Li-tao. Research on the Association Between Migraine and Cerebrovascular Disease [J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(5): 60-.
[2]	ZENG Jun-sheng, WANG Te. Effects of Ginkgo Biloba Capsule Combined with Flunarizine Hydrochloride on Intracranial Arterial Hemodynamics and Serum β-EP, 5-HT and CGRP Levels in Patients with Migraine [J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(3): 49-.
[3]	SONG Qiu-jing, WANG Juan. Discussion on the Treatment of Type 2 Diabetes from Liver and Spleen [J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(2): 58-.
[4]	ZHAO Bo, YU Ai-mei, ZOU Yu-an. Research Progress in Migraine Combined with Patent Oval Foramen [J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(2): 47-.
[5]	LI Yan-xiao, XUE Qian, ZHONG Ting-ting, et al. Correlation between Right-to-Left Cardiac Shunt and White Matter Lesions in Patients with Migraine [J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(6): 31-.
[6]	LI Yan-xiao, XUE Qian. Research Progress on the Relationship between Right to Left Cardiac Shunt and White Matter Lesions in Migraine Patients [J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(5): 34-.
[7]	HE Pan, LIU Yue-tao, DU Guan-hua, QIN Xue-mei. Research Advances in Sarcopenia [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 47-53.
[8]	LIU Nuo，WANG Zhen-zhen，CHEN Nai-hong. The Role of Gut Flora in the Pathogenesis of Alzheimer’s Disease [J]. Acta Neuropharmacologica, 2017, 7(5): 28-.
[9]	LUO Lin-ming, JI Yi-na, CHEN Nai-hong. Research Progress on the Effect of Neural Stem Cells in the Occurrence and Development of Glioma [J]. ACTA NEUROPHARMACOLOGICA, 2015, 5(5): 28-33.
[10]	WANG Ke-zhu, SUN Jun-hua, XU pan, CHEN Hong-ying, DAI Zhi, WANG Xiao-ying, LIU Xin-min. Migraine Model Rats Evoked by Nitroglycerin Decrease Autonomic Activity [J]. Acta Neuropharmacologica, 2015, 5(3): 6-11.
[11]	WANG Zhen-zhen, CHEN Nai-hong. Depression and Inflammation [J]. Acta Neuropharmacologica, 2013, 3(5): 27-37.
[12]	LIU Hong-bin，WU Hai-xia. Overview of the Pathogenesis and Animal Models of Alzheimer's Disease [J]. Acta Neuropharmacologica, 2013, 3(4): 14-22.
[13]	XUE Xiao-yan, GUO Xiao-hua, LI-Min, LUO Huan-min. Progress in Understanding the Pathogenesis of Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2011, 1(6): 37-47.